241 results on '"Uc, Ergun Y."'
Search Results
2. Reprint of: The impact of alpha-1-adrenergic receptor antagonists on the progression of Parkinson disease
3. The impact of alpha-1-adrenergic receptor antagonists on the progression of Parkinson disease
4. Driving in Parkinson’s Disease
5. A pilot dose-finding study of terazosin in humans
6. The human subthalamic nucleus transiently inhibits active attentional processes.
7. Real-life consequences of cognitive dysfunction in Parkinson's disease
8. Driving in Parkinson’s Disease
9. Driving in Parkinson’s Disease
10. The impact of alpha-1-adrenergic receptor antagonists on the progression of Parkinson disease
11. Driving Simulator Performance in Charcot-Marie-Tooth Disease Type 1A
12. Approach to Cognitive Impairment in Parkinson’s Disease
13. Digital driving data can track driving exposure and quality of life in Parkinson’s disease
14. Real‐World Driving Data Indexes Dopaminergic Treatment Effects in Parkinson's Disease
15. Digital driving data can track driving exposure and quality of life in Parkinson's disease.
16. Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis
17. Movement Disorders
18. Separating the effect of reward from corrective feedback during learning in patients with Parkinson’s disease
19. Driving Risk in Patients with Movement Disorders
20. Longitudinal decline of driving safety in Parkinson disease
21. Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health
22. Body mass index in Parkinson’s disease: A meta-analysis
23. A pilot to assess target engagement of terazosin in Parkinson's disease
24. Detection of imminent collisions by drivers with Alzheimer's disease and Parkinson's disease: A preliminary study
25. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit
26. Driving and neurodegenerative diseases
27. Driving and off-road impairments underlying failure on road testing in Parkinsonʼs disease
28. Impact of specific executive functions on driving performance in people with Parkinsonʼs disease
29. Driving Risk in Patients with Movement Disorders
30. Validation of a Screening Battery to Predict Driving Fitness in People With Parkinsonʼs Disease
31. Unsafe rear-end collision avoidance in Alzheimer's disease
32. Predictors of Driving Outcomes in Advancing Age
33. Clinical predictors of driving status in Huntingtonʼs disease
34. Cognitive Functioning Predicts Driver Safety on Road Tests 1 and 2 Years Later
35. Cerebellar Transcranial Direct Current Stimulation in People with Parkinson’s Disease: A Pilot Study
36. Driving in Parkinson Disease
37. Neuropsychological Predictors of Driving Errors in Older Adults
38. Driving difficulties in Parkinsonʼs disease
39. Impaired navigation in drivers with Parkinsonʼs disease
40. Deep Brain Stimulation in Movement Disorders
41. Expression of mRNAs of multiple growth factors and receptors by astrocytes and glioma cells: Detection with reverse transcription-polymerase chain reaction
42. Predictors of weight loss in Parkinsonʼs disease
43. Chapter 9 Clinical Trials in Parkinson's Disease
44. The midlatency auditory evoked potential P50 is abnormal in Huntington's disease
45. Childhood dystonia
46. Juvenile parkinsonism
47. Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's disease
48. Establishing an evidence-base framework for driving rehabilitation in Parkinson’s disease: A systematic review of on-road driving studies
49. Gestures make memories, but what kind? Patients with impaired procedural memory display disruptions in gesture production and comprehension
50. A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.